IBDEI0GH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,7965,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7965,1,2,0)
 ;;=2^Fundus Photography
 ;;^UTILITY(U,$J,358.3,7965,1,3,0)
 ;;=3^92250
 ;;^UTILITY(U,$J,358.3,7966,0)
 ;;=66030^^51^574^5^^^^1
 ;;^UTILITY(U,$J,358.3,7966,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7966,1,2,0)
 ;;=2^Inj Treatment of Eye,Medication
 ;;^UTILITY(U,$J,358.3,7966,1,3,0)
 ;;=3^66030
 ;;^UTILITY(U,$J,358.3,7967,0)
 ;;=67028^^51^574^6^^^^1
 ;;^UTILITY(U,$J,358.3,7967,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7967,1,2,0)
 ;;=2^Intravitreal Inj of Eye Drug
 ;;^UTILITY(U,$J,358.3,7967,1,3,0)
 ;;=3^67028
 ;;^UTILITY(U,$J,358.3,7968,0)
 ;;=67500^^51^574^10^^^^1
 ;;^UTILITY(U,$J,358.3,7968,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7968,1,2,0)
 ;;=2^Retrobulbar Inj,Medication
 ;;^UTILITY(U,$J,358.3,7968,1,3,0)
 ;;=3^67500
 ;;^UTILITY(U,$J,358.3,7969,0)
 ;;=67505^^51^574^9^^^^1
 ;;^UTILITY(U,$J,358.3,7969,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7969,1,2,0)
 ;;=2^Retrobulbar Inj,Alcohol
 ;;^UTILITY(U,$J,358.3,7969,1,3,0)
 ;;=3^67505
 ;;^UTILITY(U,$J,358.3,7970,0)
 ;;=68200^^51^574^13^^^^1
 ;;^UTILITY(U,$J,358.3,7970,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7970,1,2,0)
 ;;=2^Subconjunctival Injection
 ;;^UTILITY(U,$J,358.3,7970,1,3,0)
 ;;=3^68200
 ;;^UTILITY(U,$J,358.3,7971,0)
 ;;=96372^^51^574^11^^^^1
 ;;^UTILITY(U,$J,358.3,7971,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7971,1,2,0)
 ;;=2^SC/IM Injection
 ;;^UTILITY(U,$J,358.3,7971,1,3,0)
 ;;=3^96372
 ;;^UTILITY(U,$J,358.3,7972,0)
 ;;=96402^^51^574^12^^^^1
 ;;^UTILITY(U,$J,358.3,7972,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7972,1,2,0)
 ;;=2^SQ/IM Anti-Neplastic Hormone Inj
 ;;^UTILITY(U,$J,358.3,7972,1,3,0)
 ;;=3^96402
 ;;^UTILITY(U,$J,358.3,7973,0)
 ;;=C9257^^51^574^2^^^^1
 ;;^UTILITY(U,$J,358.3,7973,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7973,1,2,0)
 ;;=2^Bevacizumab Inj 0.25mg
 ;;^UTILITY(U,$J,358.3,7973,1,3,0)
 ;;=3^C9257
 ;;^UTILITY(U,$J,358.3,7974,0)
 ;;=J1094^^51^574^4^^^^1
 ;;^UTILITY(U,$J,358.3,7974,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7974,1,2,0)
 ;;=2^Dexamethasone Acetate Inj per 1mg
 ;;^UTILITY(U,$J,358.3,7974,1,3,0)
 ;;=3^J1094
 ;;^UTILITY(U,$J,358.3,7975,0)
 ;;=J2778^^51^574^8^^^^1
 ;;^UTILITY(U,$J,358.3,7975,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7975,1,2,0)
 ;;=2^Ranibizumab Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,7975,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,7976,0)
 ;;=J3300^^51^574^14^^^^1
 ;;^UTILITY(U,$J,358.3,7976,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7976,1,2,0)
 ;;=2^Triescence Inj per 1mg
 ;;^UTILITY(U,$J,358.3,7976,1,3,0)
 ;;=3^J3300
 ;;^UTILITY(U,$J,358.3,7977,0)
 ;;=J3301^^51^574^7^^^^1
 ;;^UTILITY(U,$J,358.3,7977,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7977,1,2,0)
 ;;=2^Kenalog Inj per 10mg
 ;;^UTILITY(U,$J,358.3,7977,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,7978,0)
 ;;=J3396^^51^574^15^^^^1
 ;;^UTILITY(U,$J,358.3,7978,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7978,1,2,0)
 ;;=2^Verteporfin Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,7978,1,3,0)
 ;;=3^J3396
 ;;^UTILITY(U,$J,358.3,7979,0)
 ;;=J9035^^51^574^3^^^^1
 ;;^UTILITY(U,$J,358.3,7979,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7979,1,2,0)
 ;;=2^Bevacizumab Inj 10mg
 ;;^UTILITY(U,$J,358.3,7979,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,7980,0)
 ;;=J0178^^51^574^1^^^^1
 ;;^UTILITY(U,$J,358.3,7980,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,7980,1,2,0)
 ;;=2^Aflibercept Inj 1mg
 ;;^UTILITY(U,$J,358.3,7980,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,7981,0)
 ;;=67028^^51^575^1^^^^1
 ;;^UTILITY(U,$J,358.3,7981,1,0)
 ;;=^358.31IA^3^2
